ACH Accendra Health, Inc.
Healthcare$2.83+4.43%ClosedMarket Cap: $216.7M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.47
P/S
0.08
EV/EBITDA
5.96
DCF Value
$-11.09
FCF Yield
-83.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
41.3%
Operating Margin
3.5%
Net Margin
-39.8%
ROE
264.5%
ROA
-44.8%
ROIC
4.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $627.8M | 39.1% | $-6.1M | $-6.5M | $— | — |
| Q4 null | $709.0M | 40.9% | $22.0M | $-56.3M | $— | — |
| FY null | $2.76B | 43.5% | $150.2M | $-1.10B | $— | — |
| Q3 null | $697.3M | 41.6% | $29.1M | $-150.3M | $— | — |
| Q2 null | $681.9M | 43.6% | $49.3M | $-869.1M | $— | — |
| Q1 null | $2.63B | 20.0% | $124.0K | $-25.0M | $— | — |
| Q4 null | $2.70B | 21.5% | $-262.0M | $-296.1M | $— | — |
| FY null | $10.70B | 20.7% | $-207.8M | $-362.7M | $— | — |
| Q3 null | $686.8M | 48.3% | $31.1M | $-12.8M | $— | — |
| Q2 null | $660.4M | 47.9% | $16.9M | $-31.9M | $— | — |
| Q1 null | $2.61B | 20.5% | $9.7M | $-21.9M | $— | — |
| Q4 2023 | $2.66B | 21.5% | $60.0M | $17.8M | $0.23 | — |